LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

Search

STAAR Surgical Co

Gesloten

SectorGezondheidszorg

28.43 -0.28

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

28.33

Max

28.66

Belangrijke statistieken

By Trading Economics

Inkomsten

37M

-17M

Verkoop

1.7M

44M

K/W

Sectorgemiddelde

55.443

34.427

Winstmarge

-37.933

Werknemers

1,157

EBITDA

48M

-23M

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

-10.54% downside

Dividenden

By Dow Jones

Volgende Winsten

29 okt 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

437M

1.4B

Vorige openingsprijs

28.71

Vorige sluitingsprijs

28.43

Nieuwssentiment

By Acuity

34%

66%

79 / 374 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Strong Bullish Evidence

STAAR Surgical Co Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

5 aug 2025, 10:10 UTC

Acquisities, Fusies, Overnames

Alcon to Buy Staar Surgical for $1.5 Billion

8 aug 2025, 13:40 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Staar Surgical's Top Holder Questions Deal -- Market Talk

5 aug 2025, 05:07 UTC

Acquisities, Fusies, Overnames

Alcon Deal Puts STARR Equity Value at Approximately $1.5 Billion. >ALC.EB

5 aug 2025, 05:07 UTC

Acquisities, Fusies, Overnames

Alcon Will Purchase All Outstanding Shares of STAAR Common Stock for $28 Per Share in Cash >ALC.EB

5 aug 2025, 05:07 UTC

Acquisities, Fusies, Overnames

Alcon Deal Represents 51% Premium to Closing Price of STAAR Common Stock on Aug. 4 >ALC.EB

5 aug 2025, 05:07 UTC

Acquisities, Fusies, Overnames

Alcon Agrees to Acquire STAAR Surgical >ALC STAA

5 aug 2025, 05:01 UTC

Acquisities, Fusies, Overnames

Alcon Agrees To Acquire STAAR Surgical >ALC STAA

Peer Vergelijking

Prijswijziging

STAAR Surgical Co Prognose

Koersdoel

By TipRanks

-10.54% neerwaarts potentieel

12 Maanden Prognose

Gemiddelde 25.38 USD  -10.54%

Hoogste 29 USD

Laagste 16 USD

Gebaseerd op 10 Wall Street-analisten die 12-maands prijsdoelen bieden voor STAAR Surgical Co - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

10 ratings

0

Buy

10

Hold

0

Sell

Technische score

By Trading Central

18.604 / 20.07Steun & Weerstand

Korte Termijn

Strong Bullish Evidence

Gemiddeld Termijn

Very Strong Bullish Evidence

Lange Termijn

No Evidence

Sentiment

By Acuity

79 / 374 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over STAAR Surgical Co

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.